US2020254039A1PendingUtilityA1

Pharmaceutical compositions containing cannabis, uses thereof and methods for improving sleep quality

Assignee: EXZELL PHARMA INCPriority: Apr 10, 2018Filed: Jan 6, 2020Published: Aug 13, 2020
Est. expiryApr 10, 2038(~11.7 yrs left)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658A61P 25/20A61K 36/84A61P 25/22A61K 36/53A61K 31/192A61K 31/05A61K 36/185A61K 31/352
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition containing cannabis for improving the quality of sleep in a patient is provided. Also provided are a use of the pharmaceutical composition for improving the quality of sleep in a patient, and methods for improving the quality of sleep. The pharmaceutical composition preferably includes a combination of therapeutically effective amounts of one or more of the following medicinal ingredients: cannabis, and/or an herb.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A caplet, capsule, dermal patch, oil drop, powder or a suspension consisting essentially of a cannabis extract, a passion flower extract and a valerian extract. 
     
     
         2 . The tablet, caplet, capsule or dermal patch of  claim 1  wherein the tablet, caplet, capsule or dermal patch includes from about 1 mg to about 30 mg of the cannabinoid extract per dose. 
     
     
         3 . The tablet, caplet, capsule or dermal patch of  claim 2  wherein the tablet, caplet, capsule or dermal patch includes from about 2 mg to about 20 mg of the cannabinoid extract per dose. 
     
     
         4 . The tablet, caplet, capsule or dermal patch of  claim 1  wherein the tablet, caplet, capsule or dermal patch includes from about 25 mg to about 3000 mg of the passion flower extract per dose. 
     
     
         5 . The tablet, caplet, capsule or dermal patch of  claim 4  wherein the tablet, caplet, capsule or dermal patch includes from about 30 mg to about 70 mg of the passion flower extract per dose. 
     
     
         6 . The tablet, caplet, capsule or dermal patch of  claim 1  wherein the tablet, caplet, capsule or dermal patch includes from about 100 mg to about 3000 mg of the valerian extract per dose. 
     
     
         7 . The tablet, caplet, capsule or dermal patch of  claim 6  wherein the tablet, caplet, capsule or dermal patch includes from about 125 mg to about 175 mg of the valerian extract per dose. 
     
     
         8 . A caplet, capsule, dermal patch, oil drop, powder or a suspension consisting essentially of a cannabis extract, a passion flower extract and a hops extract. 
     
     
         9 . The tablet, caplet, capsule or dermal patch of  claim 8  wherein the tablet, caplet, capsule or dermal patch includes from about 1 mg to about 30 mg of the cannabinoid extract per dose. 
     
     
         10 . The tablet, caplet, capsule or dermal patch of  claim 9  wherein the tablet, caplet, capsule or dermal patch includes from about 2 mg to about 20 mg of the cannabinoid extract per dose. 
     
     
         11 . The tablet, caplet, capsule or dermal patch of  claim 8  wherein the tablet, caplet, capsule or dermal patch includes from about 25 mg to about 3000 mg of the passion flower extract per dose. 
     
     
         12 . The tablet, caplet, capsule or dermal patch of  claim 11  wherein the tablet, caplet, capsule or dermal patch includes from about 30 mg to about 70 mg of the passion flower extract per dose. 
     
     
         13 . The tablet, caplet, capsule or dermal patch of  claim 8  wherein the tablet, caplet, capsule or dermal patch includes from about 2 mg to 400 mg of the hops extract per dose. 
     
     
         14 . The tablet, caplet, capsule or dermal patch of  claim 13  wherein the tablet, caplet, capsule or dermal patch includes from about 50 mg to about 100 mg of the hops extract per dose. 
     
     
         15 . A caplet, capsule, dermal patch, oil drop, powder or a suspension consisting essentially of a cannabis extract, a valerian extract and a hops extract. 
     
     
         16 . The tablet, caplet, capsule or dermal patch of  claim 15  wherein the tablet, caplet, capsule or dermal patch includes from about 1 mg to about 30 mg of the cannabinoid extract per dose. 
     
     
         17 . The tablet, caplet, capsule or dermal patch of  claim 16  wherein the tablet, caplet, capsule or dermal patch includes from about 2 mg to about 20 mg of the cannabinoid extract per dose. 
     
     
         18 . The tablet, caplet, capsule or dermal patch of  claim 15  wherein the tablet, caplet, capsule or dermal patch includes from about 100 mg to about 3000 mg of the valerian extract per dose. 
     
     
         19 . The tablet, caplet, capsule or dermal patch of  claim 18  wherein the tablet, caplet, capsule or dermal patch includes from about 125 mg to about 175 mg of the valerian extract per dose. 
     
     
         20 . The tablet, caplet, capsule or dermal patch of  claim 15  wherein the tablet, caplet, capsule or dermal patch includes from about 2 mg to 400 mg of the hops extract per dose. 
     
     
         21 . The tablet, caplet, capsule or dermal patch of  claim 20  wherein the tablet, caplet, capsule or dermal patch includes from about 50 mg to about 100 mg of the hops extract per dose.

Join the waitlist — get patent alerts

Track US2020254039A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.